Cargando…
The Synergistic Repressive Effect of NF-κB and JNK Inhibitor on the Clonogenic Capacity of Jurkat Leukemia Cells
Deregulation of Nuclear Transcription Factor-κB (NF-κB) and Jun N-terminal kinase (JNK) signaling is commonly detected in leukemia, suggesting an important role for these two signaling pathways in the pathogenesis of leukemia. In this study, using Jurkat cells, an acute T-lymphoblastic leukemia (T-A...
Autores principales: | Liu, Xinli, Zhang, Jun, Li, Jing, Volk, Andrew, Breslin, Peter, Zhang, Jiwang, Zhang, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272284/ https://www.ncbi.nlm.nih.gov/pubmed/25526629 http://dx.doi.org/10.1371/journal.pone.0115490 |
Ejemplares similares
-
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
por: Volk, Andrew, et al.
Publicado: (2014) -
Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling
por: Li, Jing, et al.
Publicado: (2016) -
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
por: Moreno-Martínez, Daniel, et al.
Publicado: (2014) -
Differential cytokine regulation by NF-κB and AP-1 in Jurkat T-cells
por: Khalaf, Hazem, et al.
Publicado: (2010) -
TLRs, NF-κB, JNK, and Liver Regeneration
por: Iimuro, Yuji, et al.
Publicado: (2010)